Skip to Content
Merck
  • Dynamics and binding modes of free cdk2 and its two complexes with inhibitors studied by computer simulations.

Dynamics and binding modes of free cdk2 and its two complexes with inhibitors studied by computer simulations.

Journal of biomolecular structure & dynamics (2002-10-02)
Michal Otyepka, Zdenek Kríz, Jaroslav Koca
ABSTRACT

This article presents a molecular dynamics (MD) study of the cdk2 enzyme and its two complexes with the inhibitors isopentenyladenine and roscovitine using the Cornell et al. force field from the AMBER software package. The results show that inserting an inhibitor into the enzyme active site does not considerably change enzyme structure but it seemingly changes the distribution of internal motions. The inhibitor causes differences in the domain motions in free cdk2 and in its complexes. It was found out that repulsion of roscovitine N9 substituent causes conformational change on Lys 33 side chain. Isopentenyladenine forms with Lys 33 side chain terminal amino group a hydrogen bond. It implies that the cavity, where N9 substituent of roscovitine is buried, can adopt larger substituent due to Lys 33 side chain flexibility. The composition of electrostatic and van der Waals interactions between the inhibitor and the enzyme were also calculated along both cdk2/inhibitor MD trajectories together with MM-PB/GBSA analysis. These results show that isopentenyladenine-like inhibitors could be more effective after modifications leading to an increase in their van der Waals contact with the enzyme. We suggest that a way leading to better inhibitors occupying isopentenyladenine binding mode could be: to keep N9 and N7 purine positions free, to keep 3,3-dimethylallylamino group at C6 position, and to add, e.g., benzylamino group at C2 position. The results support the idea that the isopentenyladenine binding mode can be used for cdk2 inhibitors design and that all possibilities to improve this binding mode were not uncovered yet.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
6-(γ,γ-Dimethylallylamino)purine, BioReagent, suitable for plant cell culture, 1 mg/mL
Sigma-Aldrich
6-(γ,γ-Dimethylallylamino)purine, BioReagent, suitable for plant cell culture, ≥98.5%
Sigma-Aldrich
6-(γ,γ-Dimethylallylamino)purine, BioReagent, suitable for plant cell culture, ≥90%